A recent study done by a team of researchers from Dana Farber Cancer Institute under the Harvard Medical School and the Massachusetts Institute of Technology has been able to unlock the conundrum surrounding thorough mapping of the genome of the prostate cancer.

Examining seven types of prostate cancer tumors following the codes of the normal tissues, the team asserted that genetic mutations plays a vital role in drafting a fighting mechanism against growth of cancer cells in the body and further, unveiled the dynamics surrounding the reaction of cancer cells when went through screening tests.

Meawhile, Levi Garraway from Harvard Medical School, the study author and oncologist at Dana Farber Cancer institute, claimed, ‘This first whole genome view shows us tantalizing evidence for several new prostate cancer genes that would have remained undiscovered”.

With this remarkable achievement in the field of prostate cancer research, the team is of the view that further probe into the underlying theory of the study, which was funded jointly by Howard Hughes Medical Institute, Prostate Cancer Foundation and the National Institutes of Health’s National Human Genome Research Institute, can produce ample solutions to combat the scourge of prostate cancer in the world.